EarlySense

About:

EarlySense develops signal-processing technology, offers EverOn, a contact-free and early detection patient supervision system.

Website: http://www.earlysense.com

Twitter/X: EarlySense_Ltd

Top Investors: Pitango VC, Mitsui & Co, Bank Hapoalim, Welch Allyn, Wells Fargo Strategic Capital

Description:

EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in 2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts.

Total Funding Amount:

$140M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ramat Gan, Tel Aviv, Israel

Founded Date:

2004-01-01

Contact Email:

info(AT)earlysense.com

Founders:

Avner Halperin, Guy Shinar

Number of Employees:

101-250

Last Funding Date:

2019-01-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai